DISEASE INDICATIONS: Acquired thrombotic thrombocytopenic purpura (aTTP)

MANUFACTURER: Ablynx NV

USAGE: Intravenous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Cablivi is a monoclonal antibody medication used to treat acquired thrombotic thrombocytopenic purpura, a rare and life-threatening condition that causes blood clots in small blood vessels and low levels of blood platelets.